Close

Bristol-Myers Squibb (BMY), PsiOxus Enter Enadenotucirev + Opdivo Combo in Tumors Evaluation Collaboration

June 30, 2016 7:00 AM EDT Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) announced an exclusive clinical collaboration agreement to evaluate the safety ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login